Anhui BBCA International Naftopidil

Anhui BBCA International Naftopidil is used for the treatment of benign prostatic hyperplasia; in addition to α1 receptor antagonism, it also has calcium antagonism, so it can not only relax the prostate and urethra smooth muscle, reduce urination resistance, but also relax the bladder smooth muscle, increase bladder capacity, and reduce Residual urine volume, reducing the frequency of urination; Another feature of this product is that it has its own unique advantages in the treatment of hypertension: the drug is a super-selective α1-adrenergic receptor blocker, and it has 5-HT1A receptors. The role of body agonists and Ca2+ channel antagonists; it has multiple hypotensive mechanisms, which can effectively control blood pressure while avoiding adverse reactions such as "first dose effect" orthostatic hypotension and reflex tachycardia. It is a long-term treatment. A new type of drug that is safe and effective for blood pressure.